Equities research analysts expect that Welltower Inc. (NYSE:HCN) will announce $1.08 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Welltower’s earnings, with the highest sales estimate coming in at $1.11 billion and the lowest estimate coming in at $1.06 billion. Welltower also reported sales of $1.08 billion in the same quarter last year. The business is expected to report its next quarterly earnings results on Wednesday, February 28th.
On average, analysts expect that Welltower will report full year sales of $1.08 billion for the current financial year, with estimates ranging from $4.19 billion to $4.41 billion. For the next financial year, analysts forecast that the company will post sales of $4.43 billion per share, with estimates ranging from $4.29 billion to $4.55 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that cover Welltower.
Welltower (NYSE:HCN) last announced its quarterly earnings results on Tuesday, November 7th. The real estate investment trust reported $1.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.03. The business had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. Welltower had a return on equity of 7.45% and a net margin of 22.67%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.16 EPS.
HCN has been the topic of a number of recent research reports. Stifel Nicolaus reduced their target price on Welltower from $75.00 to $74.00 and set a “buy” rating on the stock in a research note on Friday, November 3rd. Capital One Financial initiated coverage on Welltower in a research note on Monday, September 25th. They issued an “equal weight” rating and a $74.00 target price on the stock. Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Welltower in a research note on Wednesday, September 6th. Mizuho reaffirmed a “hold” rating and issued a $67.00 target price on shares of Welltower in a research note on Monday. Finally, KeyCorp reaffirmed a “hold” rating on shares of Welltower in a research note on Tuesday, October 17th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the stock. Welltower has an average rating of “Hold” and a consensus target price of $73.07.
Shares of Welltower (NYSE:HCN) traded up $0.29 during trading hours on Thursday, hitting $66.41. The stock had a trading volume of 2,331,100 shares, compared to its average volume of 1,778,650. The stock has a market cap of $24,530.00, a price-to-earnings ratio of 15.41, a price-to-earnings-growth ratio of 4.45 and a beta of 0.25. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.76 and a quick ratio of 1.76. Welltower has a fifty-two week low of $63.05 and a fifty-two week high of $78.17.
The company also recently disclosed a quarterly dividend, which was paid on Monday, November 20th. Stockholders of record on Tuesday, November 7th were issued a dividend of $0.87 per share. The ex-dividend date was Monday, November 6th. This represents a $3.48 dividend on an annualized basis and a dividend yield of 5.24%. Welltower’s payout ratio is 305.26%.
In other news, Director Gary Whitelaw acquired 1,420 shares of the company’s stock in a transaction dated Tuesday, November 21st. The stock was acquired at an average cost of $68.39 per share, for a total transaction of $97,113.80. Following the acquisition, the director now directly owns 1,420 shares in the company, valued at approximately $97,113.80. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.19% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in HCN. Vanguard Group Inc. boosted its position in Welltower by 0.6% in the 2nd quarter. Vanguard Group Inc. now owns 52,544,776 shares of the real estate investment trust’s stock valued at $3,932,976,000 after buying an additional 319,528 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Welltower by 11.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 7,592,729 shares of the real estate investment trust’s stock valued at $533,618,000 after buying an additional 768,861 shares during the last quarter. Principal Financial Group Inc. boosted its position in Welltower by 1.0% in the 2nd quarter. Principal Financial Group Inc. now owns 6,554,573 shares of the real estate investment trust’s stock valued at $490,611,000 after buying an additional 62,933 shares during the last quarter. Cbre Clarion Securities LLC boosted its position in Welltower by 8.3% in the 2nd quarter. Cbre Clarion Securities LLC now owns 6,401,420 shares of the real estate investment trust’s stock valued at $479,146,000 after buying an additional 492,882 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Welltower by 7.4% in the 2nd quarter. Northern Trust Corp now owns 6,122,277 shares of the real estate investment trust’s stock valued at $458,253,000 after buying an additional 424,319 shares during the last quarter. Hedge funds and other institutional investors own 86.67% of the company’s stock.
Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.